DK0579488T3 - Præparat til behandling af mastitis og matritis - Google Patents

Præparat til behandling af mastitis og matritis

Info

Publication number
DK0579488T3
DK0579488T3 DK93305506.3T DK93305506T DK0579488T3 DK 0579488 T3 DK0579488 T3 DK 0579488T3 DK 93305506 T DK93305506 T DK 93305506T DK 0579488 T3 DK0579488 T3 DK 0579488T3
Authority
DK
Denmark
Prior art keywords
mastitis
treatment
matritis
preparation
metritis
Prior art date
Application number
DK93305506.3T
Other languages
Danish (da)
English (en)
Inventor
A H J Rajamannan
Original Assignee
A H J Rajamannan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A H J Rajamannan filed Critical A H J Rajamannan
Application granted granted Critical
Publication of DK0579488T3 publication Critical patent/DK0579488T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Insulating Materials (AREA)
  • Disintegrating Or Milling (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93305506.3T 1992-07-14 1993-07-14 Præparat til behandling af mastitis og matritis DK0579488T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/913,034 US5260341A (en) 1992-07-14 1992-07-14 Product and process for treating bovine mastitis and bovine metritis

Publications (1)

Publication Number Publication Date
DK0579488T3 true DK0579488T3 (da) 1996-11-18

Family

ID=25432872

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93305506.3T DK0579488T3 (da) 1992-07-14 1993-07-14 Præparat til behandling af mastitis og matritis

Country Status (13)

Country Link
US (1) US5260341A (ja)
EP (1) EP0579488B1 (ja)
JP (1) JPH06256176A (ja)
AT (1) ATE143804T1 (ja)
AU (1) AU676473B2 (ja)
CA (1) CA2097740C (ja)
DE (1) DE69305267T2 (ja)
DK (1) DK0579488T3 (ja)
ES (1) ES2095578T3 (ja)
GR (1) GR3022030T3 (ja)
MX (1) MX9304185A (ja)
NZ (1) NZ248135A (ja)
ZA (1) ZA934021B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449517A (en) * 1993-11-22 1995-09-12 Fitzjarrell; Edwin A. Method and formulation for eliminating fleas on animals
US5622123A (en) * 1995-08-10 1997-04-22 Aqua Heat Technology, Inc. Process and apparatus for killing soil pathogens
US5846543A (en) * 1995-10-24 1998-12-08 Hassler; Mark A. Bovine mastitis treatment
DE19631037C2 (de) * 1996-08-01 2002-12-05 Boehringer Ingelheim Vetmed Neue Wirkstoffkombinationen aus bacterizid wirkenden Substanzen mit terpenhaltigen Pflanzenextrakten
GT199800140A (es) * 1997-09-12 2000-02-29 Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientos para fabricarla.
PT1054681E (pt) * 1998-02-02 2003-09-30 Boehringer Ingelheim Vetmed Utilizacao de combinacoes de agentes activos consistindo de antibioticos e extractos vegetais contendo terfeno na medicina veterinaria
NL1014260C2 (nl) * 2000-02-02 2001-08-03 Lely Entpr Ag Inrichting voor het detecteren van fysische afwijkingen in melk.
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
RU2454972C2 (ru) * 2010-03-19 2012-07-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана" Способ лечения синдрома метрит-мастит-агалактия (мма) у свиноматок
CN104095900A (zh) * 2014-07-11 2014-10-15 上海育生堂科技有限公司 一种用于通乳的可清热解毒、排毒透脓的中药酒膏药
CN104721393A (zh) * 2015-03-24 2015-06-24 臧兰恕 一种治疗热毒炽盛型乳痈的中药组合物
RU2699723C1 (ru) * 2019-01-14 2019-09-09 Общество с ограниченной ответственностью "Агровейт" Препарат "райдо" для профилактики и лечения маститов у коров и способ его получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904780A (en) * 1973-05-30 1975-09-09 Suntory Ltd Method for giving and increasing the flavor resembling to dairy product
US4320149A (en) * 1979-10-15 1982-03-16 Minnesota Mining And Manufacturing Company Use of fluorinated beta-diketones as antiplaque agents
JPS5929618A (ja) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd 虫歯防止剤
US5147652A (en) * 1990-07-03 1992-09-15 Cell Research Corporation Autobiotics and their use in eliminating nonself cells in vivo

Also Published As

Publication number Publication date
GR3022030T3 (en) 1997-03-31
AU676473B2 (en) 1997-03-13
DE69305267D1 (de) 1996-11-14
CA2097740C (en) 2002-03-26
CA2097740A1 (en) 1994-01-15
US5260341A (en) 1993-11-09
NZ248135A (en) 1995-10-26
EP0579488B1 (en) 1996-10-09
ES2095578T3 (es) 1997-02-16
AU4148693A (en) 1994-01-20
ZA934021B (en) 1995-01-16
ATE143804T1 (de) 1996-10-15
MX9304185A (es) 1994-04-29
DE69305267T2 (de) 1997-03-13
JPH06256176A (ja) 1994-09-13
EP0579488A1 (en) 1994-01-19

Similar Documents

Publication Publication Date Title
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
GR870518B (en) Herbicide compositions based on biscarbamate and method of herbicide treatment using said compositions
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
DK152791D0 (da) Fremgangsmaade til semisyntese af humant insulin og achromobacter protease i til anvendelse derved
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
DE69304266T2 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
GR3002328T3 (en) 2-(benzhydrylsulfonyl) acetamide, process for its preparation and its therapeutical use
DE3767055D1 (de) N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
UA7413A1 (uk) Спосіб лікування псоріазу
DK169087D0 (da) Praeparat til prophylakse og behandling af svinesygdomme
CS297486A1 (en) Agent for wood species' wounds treatment
EP0267402A3 (en) Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin